Close Menu

NEW YORK — The US Food and Drug Administration on Friday granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by DxTerity Diagnostics and the Texas Department of State Health Services (DSHS).

The DxTerity SARS-CoV-2 RT-PCR Test is designed to detect the virus' N, S, and ORF1ab genes in saliva specimens. RNA extraction is performed using Thermo Fisher Scientific's Applied Biosystems MagMax 96 Magnetic Particle Processor and the test runs on the Applied Biosystems ViiA 7 Real-Time PCR System.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.